My ePortfolio Register   

Biomarker research in breast cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.07.17
Views: 247
Rating:

Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium

Prof Piccart speaks with ecancer at WIN 2017 about issues facing translational research, and the need to look beyond individual biomarkers to characterise a whole-cell understanding on cancer.

She outlines her priorities in determining how chemotherapy regimens could be reduced or phased out entirely with immune therapies, and considers how ongoing surveillance of tumour genomics may offer immediate insight into treatment response.

The clinical utility of serial biopsies was also discussed by Dr Daniel Hayes, here.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence